Affiliations 1 Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. 2 Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. wangnadoris@12com.
Despite the use of various therapies such as hematopoietic stem cell transplantation and chimeric antigen receptor T cell therapy , the prognosis of patients with acute myeloid leukemia is still generally poor. However, immunotherapy is currently a hot topic in the treatment of hematological tumors. Extracellular adenosine triphosphate can be converted to adenosine diphosphate via CD39, and ADP can be converted to adenosine via CD73, which can bind to P1 and P2 receptors to exert immunomodula...更多
Despite the use of various therapies such as hematopoietic stem cell transplantation and chimeric antigen receptor T cell therapy , the prognosis of patients with acute myeloid leukemia is still generally poor. However, immunotherapy is currently a hot topic in the treatment of hematological tumors. Extracellular adenosine triphosphate can be converted to adenosine diphosphate via CD39, and ADP can be converted to adenosine via CD73, which can bind to P1 and P2 receptors to exert immunomodulatory effects. Research on the mechanism of the purinergic signaling pathway can provide a new direction for the treatment of AML, and inhibitors of this signaling pathway have been discovered by several researchers and gradually applied in the clinic. In this paper, the mechanism of the purinergic signaling pathway and its clinical application are described, revealing a new target for the treatment of AML and subsequent improvement in patient prognosis.收起
